{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:47:17Z","timestamp":1786787237387,"version":"build-2736575974"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mast cell tumors (MCTs) with bone marrow (BM) involvement are poorly documented in dogs and are associated with a poor prognosis. Successful treatment strategies have not been described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Clinicopathologic findings of affected dogs are not specific. Administration of lomustine or imatinib is beneficial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Fourteen dogs with MCT and BM involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical and laboratory evaluations were performed in each dog on admission and during follow-up. All dogs received prednisone. Additionally, 8 dogs received lomustine and 3 dogs received imatinib. Imatinib was administered if tumor-associated tyrosine kinase KIT was aberrant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>On admission, 11 dogs had a single cutaneous nodule and 3 dogs had multiple nodules. Involvement of regional lymph nodes, liver, or spleen was observed in each dog. BM infiltration with mast cells (MCs) was observed in all dogs. On CBC, nonregenerative anemia, leukopenia, or thrombocytopenia was common. Four dogs had circulating MCs. Increased alkaline phosphatase or alanine transferase activity was observed in 12 and 10 dogs, respectively. Treatment with lomustine induced partial remission in 1 of 8 dogs. Median survival time was 43 days (range, 14\u201357). Dogs on imatinib experienced complete remission. Two dogs survived for 117 and 159 days, and the third was alive after 75 days. Dogs treated symptomatically did not improve and were euthanized after 1, 14, and 32 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>A combination of clinical and laboratory evaluation helps in identifying dogs with MCT and BM infiltration. Administration of lomustine is not helpful in affected dogs. The beneficial effect of imatinib warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2008.0128.x","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T11:12:46Z","timestamp":1232622766000},"page":"1001-1007","source":"Crossref","is-referenced-by-count":59,"title":["Clinicopathological Features and Outcome for Dogs with Mast Cell Tumors and Bone Marrow Involvement"],"prefix":"10.1093","volume":"22","author":[{"given":"L.","family":"Marconato","sequence":"first","affiliation":[{"name":"Clinica Veterinaria L'Arca , Naples,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bettini","sequence":"additional","affiliation":[{"name":"University of Bologna Department of Veterinary Public Health and Animal Pathology, , Ozzano Emilia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Giacoboni","sequence":"additional","affiliation":[{"name":"Clinica Veterinaria L'Arca , Naples,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Romanelli","sequence":"additional","affiliation":[{"name":"Clinica Veterinaria Nerviano , Milano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cesari","sequence":"additional","affiliation":[{"name":"University of Bologna Department of Veterinary Public Health and Animal Pathology, , Ozzano Emilia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zatelli","sequence":"additional","affiliation":[{"name":"Clinica Veterinaria Pirani , Reggio Emilia,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zini","sequence":"additional","affiliation":[{"name":"Vetsuisse Faculty, University of Z\u00fcrich Clinic for Small Animal Internal Medicine, , Z\u00fcrich,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,1]]},"reference":[{"key":"2026020304230133000_b1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1748-5827.1973.tb06891.x","article-title":"The prognosis following surgical removal of mastocytomas in dogs","volume":"14","author":"Bostock","year":"1973","journal-title":"J Small Anim Pract"},{"key":"2026020304230133000_b2","first-page":"469","article-title":"Canine cutaneous mast cell tumour","volume":"21","author":"Patnaik","year":"1984","journal-title":"Morphologic grading and survival time in 83 dogs"},{"key":"2026020304230133000_b3","first-page":"402","volume-title":"Small Animal Clinical Oncology","author":"Thamm","year":"2007","edition":"4th ed"},{"key":"2026020304230133000_b4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1939-1676.1987.tb01990.x","article-title":"Systemic mastocytosis in 16 dogs","volume":"1","author":"O'Keefe","year":"1987","journal-title":"J Vet Intern Med"},{"key":"2026020304230133000_b5","first-page":"222","article-title":"Visceral mast cell tumors in dogs","volume":"216","author":"Takahashi","year":"2000","journal-title":"10 cases (1982\u20131997)"},{"key":"2026020304230133000_b6","first-page":"235","volume-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2000","edition":"4th ed"},{"key":"2026020304230133000_b7","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2460\/javma.1992.200.11.1648","article-title":"Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs","volume":"200","author":"Bookbinder","year":"1992","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304230133000_b8","first-page":"355","article-title":"Frequency and severity of mastocytemia in dogs with and without mast cell tumors","volume":"215","author":"McManus","year":"1999","journal-title":"120 cases (1995\u20131997)"},{"key":"2026020304230133000_b9","first-page":"435","article-title":"Disseminated malignant mastocytoma in a dog","volume":"27","author":"Pollack","year":"1991","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304230133000_b10","first-page":"361","article-title":"Noncutaneous systemic mastocytosis and mast cell leukemia in a dog","volume":"17","author":"Davies","year":"1981","journal-title":"Case report and literature review"},{"key":"2026020304230133000_b11","first-page":"355","article-title":"Disseminated anaplastic mastocytoma with terminal mastocythemia in a dog","volume":"17","author":"Lester","year":"1981","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304230133000_b12","first-page":"31","article-title":"Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumours","volume":"5","author":"Endicott","year":"2007","journal-title":"157 cases (1999\u20132002)"},{"key":"2026020304230133000_b13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1939-1676.2006.tb01811.x","article-title":"A retrospective study of the incidence and the classification of bone marrow disorders in the dog at a veterinary teaching hospital (1996\u20132004)","volume":"20","author":"Weiss","year":"2006","journal-title":"J Vet Intern Med"},{"key":"2026020304230133000_b14","first-page":"91","article-title":"Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment","volume":"228","author":"Mullins","year":"2006","journal-title":"54 cases (1998\u20132004)"},{"key":"2026020304230133000_b15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1740-8261.1998.tb00326.x","article-title":"Radiation therapy for incompletely resected canine mast cell tumors","volume":"39","author":"LaDue","year":"1998","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020304230133000_b16","first-page":"4585","article-title":"Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors","volume":"26","author":"Spugnini","year":"2006","journal-title":"Anticancer Res"},{"key":"2026020304230133000_b17","first-page":"2207","article-title":"Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer","volume":"4","author":"Frimberger","year":"1998","journal-title":"Clin Cancer Res"},{"key":"2026020304230133000_b18","first-page":"491","article-title":"Prednisone and vinblastine chemotherapy for canine mast cell tumor","volume":"13","author":"Thamm","year":"1999","journal-title":"41 cases (1992\u20131997)"},{"key":"2026020304230133000_b19","first-page":"581","article-title":"Outcome and prognostic factors following adjuvant prednisone\/vinblastine chemotherapy for high-risk canine mast cell tumour","volume":"68","author":"Thamm","year":"2006","journal-title":"61 cases"},{"key":"2026020304230133000_b20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1476-5829.2007.00135.x","article-title":"Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours","volume":"5","author":"Hayes","year":"2007","journal-title":"Vet Comp Onc"},{"key":"2026020304230133000_b21","first-page":"156","article-title":"Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone","volume":"5","author":"Camps-Palau","year":"2007","journal-title":"35 cases (1997\u20132004)"},{"key":"2026020304230133000_b22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1939-1676.1999.tb02217.x","article-title":"Treatment of canine mast cell tumors with CCNU (lomustine)","volume":"13","author":"Rassnick","year":"1999","journal-title":"J Vet Intern Med"},{"key":"2026020304230133000_b23","first-page":"5729","article-title":"Proof of target for SU11654","volume":"9","author":"Pryer","year":"2003","journal-title":"Inhibition of KIT phosphorylation in canine mast cell tumors"},{"key":"2026020304230133000_b24","first-page":"2755","article-title":"Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies","volume":"9","author":"London","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2026020304230133000_b25","first-page":"104","article-title":"The role of c-KIT in tumorigenesis","volume":"8","author":"Webster","year":"2006","journal-title":"Evaluation in canine cutaneous mast cell tumors"},{"key":"2026020304230133000_b26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0301-472X(98)00075-7","article-title":"Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit","volume":"27","author":"London","year":"1999","journal-title":"Exp Hematol"},{"key":"2026020304230133000_b27","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2460\/ajvr.2002.63.1718","article-title":"Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs","volume":"63","author":"Downing","year":"2002","journal-title":"Am J Vet Res"},{"key":"2026020304230133000_b28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1354\/vp.39-5-529","article-title":"Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs","volume":"39","author":"Zemke","year":"2002","journal-title":"Vet Pathol"},{"key":"2026020304230133000_b29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2407-6-85","article-title":"Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors","volume":"6","author":"Webster","year":"2006","journal-title":"BMC Cancer"},{"key":"2026020304230133000_b30","first-page":"298","article-title":"Cellular proliferation in canine cutaneous mast cell tumors","volume":"44","author":"Webster","year":"2007","journal-title":"Associations with c-KIT and its role in prognostication"},{"key":"2026020304230133000_b31","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.exphem.2007.06.005","article-title":"Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells","volume":"35","author":"Gleixner","year":"2007","journal-title":"Exp Hematol"},{"key":"2026020304230133000_b32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1476-5810.2004.00059.x","article-title":"Kinase inhibitors in cancer therapy","volume":"2","author":"London","year":"2004","journal-title":"Vet Comp Onc"},{"key":"2026020304230133000_b33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.rvsc.2006.06.006","article-title":"The tyrosine kinase inhibitor imatinib [STI571] induces regression of xenografted canine mast cell tumors in SCID mice","volume":"82","author":"Kobie","year":"2007","journal-title":"Res Vet Sci"},{"key":"2026020304230133000_b34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1939-1676.2005.tb02778.x","article-title":"A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor-bearing cats","volume":"19","author":"Lachowicz","year":"2005","journal-title":"J Vet Intern Med"},{"key":"2026020304230133000_b35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vetimm.2006.07.004","article-title":"Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate","volume":"114","author":"Isotani","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"2026020304230133000_b36","first-page":"7","volume-title":"TNM Classification of Tumors in Domestic Animals","author":"Owen","year":"1980","edition":"1st ed"},{"key":"2026020304230133000_b37","first-page":"935","article-title":"Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukaemia","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2026020304230133000_b38","first-page":"194","article-title":"Veterinary cooperative oncology group \u2013 common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats","volume":"2","author":"Veterinary Cooperative Oncology Group","year":"2004","journal-title":"Vet Comp Onc"},{"key":"2026020304230133000_b39","first-page":"310","article-title":"Isoenzymes of canine plasma alkaline phosphatase","volume":"34","author":"Eckersall","year":"1983","journal-title":"An investigation using isoelectric focusing and related to diagnosis"},{"key":"2026020304230133000_b40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1354\/vp.41-4-371","article-title":"The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors","volume":"41","author":"Webster","year":"2004","journal-title":"Vet Pathol"},{"key":"2026020304230133000_b41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2460\/javma.232.1.53","article-title":"Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs","volume":"232","author":"Stanclift","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304230133000_b42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"2026020304230133000_b43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jnci\/djh131","article-title":"Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer","volume":"96","author":"Pegram","year":"2004","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2008.0128.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/4\/1001\/66674830\/j.1939-1676.2008.0128.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/22\/4\/1001\/66674830\/j.1939-1676.2008.0128.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:23:14Z","timestamp":1770110594000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/22\/4\/1001\/8450115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2008.0128.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,7]]},"published":{"date-parts":[[2008,7,1]]}}}